NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 28 July 2009

Albemarle sees fine chemicals income decline 80%

Albemarle's Fine Chemicals business saw sales decline 32% to $104m in Q2 2009, and income decline from $24.5m to $5.2m. The company attributed the declines to reduced sales and production volumes but is encouraged by a strong new product pipeline for the second half of the year.
RTT

No comments: